U.S. FDA declines to approve GSK drugs division's long acting HIV injection

A GlaxoSmithKline logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls

ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety. The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen’s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination.

It’s a great news for all those living with the virus, that a monthly injection alternate is right now being very seriously discussed and closely reviewed! livingwithhiv

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves first-ever vaccine for prevention of Ebola virusThe US Food and Drug administration has approved for the first time in the United States a vaccine for the prevention of the deadly Ebola virus, the agency announced Thursday. WTF This is important CharlizeAfrica hopefully we can help other countries with this vaccine
Source: CNN - 🏆 4. / 95 Read more »

FDA targets e-cigs that hook teens but don't help smokers quitBy May, e-cigarette makers must submit applications to the FDA proving that their products provide a net benefit to public health. FreeChrystulKizer SignThePetition RetweetPlease I imagine tobacco will do the same US_FDA FDA_Drug_Info ? Too little too late. Deaths are on the rise.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »